NIW Approved for Quantum Physics Researcher Advancing Photonic Materials and Quantum Technologies

Client’s Testimonial:

“I would like to thank you for all your help and communication.”

On March 12^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Research Assistant in the Field of Quantum Optics (Approval Notice).

General Field: Quantum Optics

Position at the Time of Case Filing: Graduate Research Assistant

Country of Origin: Bangladesh

State of Residence at the Time of Filing: New York

Approval Notice Date: March 12^th, 2025

Processing Time: 1 year, 4 months

Case Summary:

We are pleased to share the approval of a National Interest Waiver (NIW) petition for a researcher from Bangladesh, whose academic career and published work significantly advance key areas of quantum materials and light-matter interaction. At the time of filing, the client was engaged in cutting-edge research in physics with a focus on quantum dots, exciton-polaritons, and light-induced photochemical reactions. His work contributes to national interests by improving the efficiency of photonic devices, supporting pharmaceutical development, and facilitating quantum information processing.

Pioneering Research in Light-Matter Interactions and Nanomaterials

Our client’s proposed endeavor centers on utilizing optical spectroscopy and quantum simulations to control and understand the interaction between photons and nanoscale materials. By studying exciton-polaritons and optical properties of quantum dots, he has been working toward transformative technologies in quantum computing and optoelectronics. His research also supports breakthroughs in pharmaceutical compound design by demonstrating how laser-based control of molecular dynamics can accelerate pharmaceutical reactions.

These efforts align closely with national priorities in quantum information science, precision medicine, and photonic engineering.

Research Impact and Scientific Contributions

To illustrate the impact of the client’s research, we presented the following evidence:

● 2 peer-reviewed journal publications
● 4 peer-reviewed conference papers
● 1 e-book
● 34 total citations to date

His work has received citations from researchers in the United States, Japan, Canada, and other countries. One of his articles was listed among the top 10% most cited publications in its field and year. These metrics reflect both the novelty and adoption of his work across interdisciplinary fields, including chemistry, physics, and photonics.

Well Positioned to Advance the Proposed Endeavor

Our legal argument emphasized the client’s unique qualifications and strong alignment with U.S. strategic interests in quantum technology. His experience in designing spectroscopy systems, investigating exciton-polariton dynamics, and applying state-of-the-art optical methods provides him with the tools to contribute immediately and meaningfully to national R&D efforts. He is also well-prepared to collaborate on federally supported quantum science initiatives that require highly specialized knowledge in nanophotonics.

Approval and Outcome

The petition was filed in November 2023 and approved in March 2025. This result reflects the strength of the client’s profile and the clarity of our presentation of his case. His work exemplifies how fundamental physics research can produce practical innovations that strengthen U.S. competitiveness in science and technology.

We are proud to support outstanding researchers like this client and look forward to seeing the continuing impact of his work in quantum optics and photonic science.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.